|
dt1121
|
54670067
|
Ascorbic Acid
|
4780
|
NFE2L2
|
Homo sapiens (human)
|
--
|
--
|
Details
|
|
dt1122
|
54670067
|
Ascorbic Acid
|
9962
|
SLC23A2
|
Homo sapiens (human)
|
--
|
--
|
Details
|
|
dt1123
|
54670067
|
Ascorbic Acid
|
5351
|
PLOD1
|
Homo sapiens (human)
|
--
|
--
|
Details
|
|
dt1124
|
54670067
|
Ascorbic Acid
|
5617
|
PRL
|
Homo sapiens (human)
|
--
|
--
|
Details
|
|
dt1125
|
54670067
|
Ascorbic Acid
|
2670
|
GFAP
|
Homo sapiens (human)
|
--
|
--
|
Details
|
|
dt1126
|
54670067
|
Ascorbic Acid
|
1634
|
DCN
|
Homo sapiens (human)
|
--
|
--
|
Details
|
|
dt1127
|
54670067
|
Ascorbic Acid
|
1588
|
CYP19A1
|
Homo sapiens (human)
|
--
|
--
|
Details
|
|
dt1128
|
54670067
|
Ascorbic Acid
|
572
|
BAD
|
Homo sapiens (human)
|
29992683
|
[juglone co-treated with ascorbic acid] results in increased expression of BAD protein
|
Details
|
|
dt1129
|
54670067
|
Ascorbic Acid
|
208
|
AKT2
|
Homo sapiens (human)
|
30597948
|
Ascorbic acid affects the expression of AKT2 mRNA
|
Details
|
|
dt1130
|
54670067
|
Ascorbic Acid
|
59
|
ACTA2
|
Homo sapiens (human)
|
17053324
|
[mercaptoethanol co-treated with ascorbic acid] results in increased expression of ACTA2 protein
|
Details
|